Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein

September 22, 2016 5:38 PM EDT Send to a Friend

Sarepta Therapeutics (NASDAQ: SRPT) offering 4-5x oversubscribed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein

Member Login

Free News Feed